Stock 512 GRAND PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Grand Pharmaceutical Group Limited

Equities

512

BMG210A71016

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 09:50:35 2024-04-28 pm EDT 		5-day change 1st Jan Change
4.43 HKD +2.55% Intraday chart for Grand Pharmaceutical Group Limited +11.28% +8.56%
Mar. 27 Grand Pharmaceutical Group Limited Enters into Strategic Cooperation Agreement for Product Introduction with LianBio Development (HK) Limited and Tarsus Pharmaceuticals, Inc CI
Mar. 25 Grand Pharma Receives Green Light for Phase III Trials of Cancer Drug MT

Business Summary

Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a Hong Kong-based investment holding company principally engaged in the manufacturing and sales of pharmaceutical preparations and medical devices. The Company is principally engaged in manufacturing and sales of pharmaceutical preparations and medical devices, bio-technology products, nutrition products, specialized pharmaceutical raw materials and other products. The main products of the Company cover the anti-tumor, cardiovascular emergency pharmaceutical products and advanced cerebro-cardiovascular intervention advanced medical devices, anti-virus and anti-infection, respiratory and ear-nose-throat (ENT), bio-health products and specialized pharmaceutical ingredients.

Sales per Business

HKD in Million2022Weight2023Weight Delta
Pharmaceutical Preparations and Medical Devices
64.7 %
5,677 59.4 % 6,813 64.7 % +20.01%
Bio-technology Products and Health Products
32.1 %
2,885 30.2 % 3,381 32.1 % +17.18%
Specialised Pharmaceutical Raw Materials and Other Products
3.2 %
1,000 10.5 % 335 3.2 % -66.45%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
82.8 %
7,454 77.9 % 8,722 82.8 % +17.01%
America
6.5 %
956 10.0 % 687 6.5 % -28.09%
Europe
5.3 %
567 5.9 % 562 5.3 % -0.76%
Asia
4.9 %
481 5.0 % 512 4.9 % +6.51%
Others
0.4 %
105 1.1 % 46 0.4 % -56.36%

Managers

Managers TitleAgeSince
Chao Zhou CEO
 Chief Executive Officer 34 19-03-31
Tin Chung Foo SEC
 Corporate Secretary 56 11-08-31

Members of the board

Members of the board TitleAgeSince
Tosi Wan So BRD
 Director/Board Member 61 05-03-20
Ye Bi Hu BRD
 Director/Board Member 60 18-12-30
Geng Pei BRD
 Director/Board Member 64 11-05-11
Chao Zhou CEO
 Chief Executive Officer 34 19-03-31
Wei Kun Tang CHM
 Chairman 39 21-05-31
Linda Shi BRD
 Director/Board Member 60 21-05-31
Yang Guang BRD
 Director/Board Member 48 23-06-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,549,571,000 1,007,647,645 ( 28.39 %) 47,761,500 ( 1.346 %) 28.39 %

Shareholders

NameEquities%Valuation
Kai Jun Hu
55.15 %
1,957,710,302 55.15 % 1 028 M $
CDH Investments Management (Hong Kong) Ltd.
10.05 %
356,648,142 10.05 % 187 M $
GL Capital Group
5.048 %
179,173,959 5.048 % 94 M $
Tong Chau
1.170 %
41,520,000 1.170 % 22 M $
Bosera Asset Management Co., Ltd.
0.3508 %
12,452,500 0.3508 % 7 M $
China Asset Management Co., Ltd.
0.0935 %
3,318,500 0.0935 % 2 M $
E Fund Asset Management Co. Ltd.
0.0573 %
2,033,500 0.0573 % 1 M $
Penghua Fund Management Co., Ltd.
0.0448 %
1,591,500 0.0448 % 835 760 $
Dimensional Fund Advisors Ltd.
0.0301 %
1,067,415 0.0301 % 560 542 $
Pheim Asset Management Sdn. Bhd.
0.0207 %
734,500 0.0207 % 385 715 $

Holdings

NameEquities%Valuation
TELIX PHARMACEUTICALS LIMITED
3.38%
 10,947,181 3.38% 92,059,662 $
ONCOSEC MEDICAL INCORPORATED
21.41%
 1,276,849 21.41% 0 $

Company contact information

Grand Pharmaceutical Group Ltd.

Units 3302, 33/F The Center

, Hong Kong

+

http://www.chinagrandpharm.com
address Grand Pharmaceutical Group Limited(512)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.32
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GRAND PHARMACEUTICAL GROUP LIMITED Stock Grand Pharmaceutical Group Limited
+8.56% 1.93B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 512 Stock
  4. Company Grand Pharmaceutical Group Limited